Login Register Cart 0
Generic placeholder image

Letters in Drug Design & Discovery

Editor-in-Chief

ISSN (Print): 1570-1808
ISSN (Online): 1875-628X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Design, Synthesis and Cytotoxicity of Novel Coumarin-1,2,3-triazole-1,2,4- Oxadiazole Hybrids as Potent Anti-breast Cancer Agents

Author(s): Maryam Mohammadi-Khanaposhtani, Kiana Fahimi, Elahe Karimpour-Razkenari, Maliheh Safavi, Mohammad Mahdavi, Mina Saeedi and Tahmineh Akbarzadeh*

Volume 16, Issue 7, 2019

Page: [818 - 824] Pages: 7

DOI: 10.2174/1570180815666180627121006

Price: $65

Abstract

Background: This work reports design, synthesis, and in vitro cytotoxicity of novel coumarin-1,2,3-triazole-1,2,4-oxadiazole hybrids against three breast cancer cell lines MCF-7, MDA-MB-231, and T-47D.

Methods: Synthetic procedure for the preparation of desired compounds was started from the reaction of coumarins or with propargyl bromide to give O-propargylated coumarins or 5. Then, click reaction between the later compounds and 3-aryl-5-(chloromethyl)-1,2,4-oxadiazoles afforded the desired products in good yields.

Results: Among the synthesized compounds, 4-((1-((3-(4-chlorophenyl)-1,2,4-oxadiazol-5- yl)methyl)-1H-1,2,3-triazol-4-yl)methoxy)-2H-chromen-2-one (9a) showed the best cytotoxicity against breast cancer cell lines.

Conclusion: Compound 9a depicted the most activity toward MDA-MB-231 and T-47D cells while compounds 8a and 8c were the most potent compounds against MCF-7.

Keywords: Anti-breast cancer, coumarin, cytotoxicity, 1, 2, 4-oxadiazole, 1, 2, 3-triazole, in vitro.

« Previous
Graphical Abstract

[1]
Murphy, S.L.; Xu, J.; Kochanek, K.D. Deaths: Final data for 2010. Natl. Vital Stat. Rep., 2013, 61(4), 1-117.
[2]
Siegel, R.; Ward, E.; Brawley, O.; Jemal, A. Cancer statistics. CA Cancer J. Clin., 2011, 61, 212-236.
[3]
Ott, I. On the medicinal chemistry of gold complexes as anticancer drugs. Coord. Chem. Rev., 2009, 253, 1670-1681.
[4]
Ott, I.; Metzler-Nolte, N. Organometallic anticancer compounds. J. Med. Chem., 2010, 54, 3-25.
[5]
Maftei, E.; Maftei, C.V.; Jones, P.G.; Freytag, M.; Franz, M.H.; Kelter, G.; Fiebig, H.H.; Tamm, M.; Neda, I. Trifluoromethylpyridinesubstituted Nheterocyclic carbenes related to natural products: Synthesis, structure, and potential antitumor activity of some corresponding gold (I), rhodium (I), and iridium (I) complexes. Helv. Chim. Acta, 2016, 99, 469-481.
[6]
Maftei, E.; Maftei, C.V.; Franz, M.H.; Kelter, G.; Fiebig, H.H.; Tamm, M.; Neda, I. New members of the cinchona alkaloid family: Synthesis, characterisation and antitumor evaluation of novel gold (I) complexes. Rev. Roum. Chim., 2016, 61, 251-260.
[7]
Emami, S.; Dadashpour, S. Current developments of coumarin-based anti-cancer agents in medicinal chemistry. Eur. J. Med. Chem., 2015, 102, 611-630.
[8]
Conley, D.; Marshall, E.M. Effects of coumarin on human-tumor cell-growth and cell-cycle analysis in-vitro. Proc. Am. Assoc. Cancer Res., 1987, 28, 63.
[9]
Tripathi, V.K.; Singh, J.; Ara, T.; Koul, S.; Farooq, S.; Kaul, A. Synthesis and biological evaluation of novel isoxazoles and triazoles linked 6-hydroxycoumarin as potent cytotoxic agents. Bioorg. Med. Chem. Lett., 2014, 24, 4243-4246.
[10]
Aufort, M.; Herscovici, J.; Bouhours, P.; Moreau, N.; Girard, C. Synthesis and antibiotic activity of a small molecules library of 1, 2, 3-triazole derivatives. Bioorg. Med. Chem. Lett., 2008, 18, 1195-1198.
[11]
Holla, B.S.; Mahalinga, M.; Karthikeyan, M.S.; Poojary, B.; Akberali, P.M.; Kumari, N.S. Synthesis, characterization and antimicrobial activity of some substituted 1,2,3-triazoles. Eur. J. Med. Chem., 2005, 40, 1173-1178.
[12]
MohammadiKhanaposhtani. M.; Mahdavi, M.; Saeedi, M.; Sabourian, R.; Safavi, M.; Khanavi, M.; Foroumadi, A.; Shafiee, A.; Akbarzadeh, T. Design, synthesis, biological evaluation, and docking study of acetylcholinesterase inhibitors: New acridone1,2,4oxadiazole1,2,3triazole hybrids. Chem. Biol. Drug Des., 2015, 86, 1425-1432.
[13]
Mohammadi-Khanaposhtani, M.; Saeedi, M.; Zafarghandi, N.S.; Mahdavi, M.; Sabourian, R.; Razkenari, E.K.; Alinezhad, H.; Khanavi, M.; Foroumadi, A.; Shafiee, A.; Akbarzadeh, T. Potent acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, and docking study of acridone linked to 1, 2, 3-triazole derivatives. Eur. J. Med. Chem., 2015, 92, 799-806.
[14]
Mohammadi-Khanaposhtani, M.; Safavi, M.; Sabourian, R.; Mahdavi, M.; Pordeli, M.; Saeedi, M.; Ardestani, S.K.; Foroumadi, A.; Shafiee, A.; Akbarzadeh, T. Design, synthesis, in vitro cytotoxic activity evaluation, and apoptosis-induction study of new 9(10H)-acridinone-1,2,3-triazoles. Mol. Divers., 2015, 19, 787-795.
[15]
Ma, N.; Wang, Y.; Zhao, B.X.; Ye, W.C.; Jiang, S. The application of click chemistry in the synthesis of agents with anticancer activity. Drug Des. Devel. Ther., 2015, 9, 1585.
[16]
Mohammadi-Khanaposhtani, M.; Shabani, M.; Faizi, M.; Aghaei, I.; Jahani, R.; Sharafi, Z.; Zafarghandi, N.S.; Mahdavi, M.; Akbarzadeh, T.; Emami, S.; Shafiee, A. Design, synthesis, pharmacological evaluation, and docking study of new acridone-based 1, 2, 4-oxadiazoles as potential anticonvulsant agents. Eur. J. Med. Chem., 2016, 112, 91-98.
[17]
Leite, L.F.C.; Ramos, M.N.; da Silva, J.B.P.; Miranda, A.L.; Fraga, C.A.; Barreiro, E.J. Synthesis and analgesic profile of novel N-containing heterocycle derivatives: Arylidene 3-phenyl-1,2,4-oxadiazole-5-carbohydrazide. Il Farmaco., 1999, 54, 747-757.
[18]
Zhang, H.Z.; Kasibhatla, S.; Kuemmerle, J.; Kemnitzer, W.; Ollis-Mason, K.; Qiu, L.; Crogan-Grundy, C.; Tseng, B.; Drewe, J.; Cai, S.X. Discovery and structure-activity relationship of 3-aryl-5-aryl-1, 2, 4-oxadiazoles as a new series of apoptosis inducers and potential anticancer agents. J. Med. Chem., 2005, 48, 5215-5223.
[19]
Maftei, C.V.; Fodor, E.; Jones, P.G.; Freytag, M.; Franz, M.H.; Kelter, G.; Fiebig, H.H.; Tamm, M.; Neda, I. N-heterocyclic carbenes (NHC) with 1, 2, 4-oxadiazole-substituents related to natural products: Synthesis, structure and potential antitumor activity of some corresponding gold (I) and silver (I) complexes. Eur. J. Med. Chem., 2015, 101, 431-441.
[20]
Maftei, C.V.; Fodor, E.; Jones, P.G.; Daniliuc, C.G.; Franz, M.H.; Kelter, G.; Fiebig, H.H.; Tamm, M.; Neda, I. Novel 1, 2, 4-oxadiazoles and trifluoromethylpyridines related to natural products: Synthesis, structural analysis and investigation of their antitumor activity. Tetrahedron, 2016, 72, 1185-1199.
[21]
Maftei, C.V.; Fodor, E.; Jones, P.G.; Franz, M.H.; Kelter, G.; Fiebig, H.; Neda, I. Synthesis and characterization of novel bioactive 1, 2, 4-oxadiazole natural product analogs bearing the N-phenylmaleimide and N-phenylsuccinimide moieties. Beilstein J. Org. Chem., 2013, 9, 2202.
[22]
Mehrabi, F.; Pourshojaei, Y.; Moradi, A.; Sharifzadeh, M.; Khosravani, L.; Sabourian, R.; Rahmani-Nezhad, S.; Mohammadi-Khanaposhtani, M.; Mahdavi, M.; Asadipour, A.; Rahimi, H.R. Design, synthesis, molecular modeling and anticholinesterase activity of benzylidene-benzofuran-3-ones containing cyclic amine side chain. Future Med. Chem., 2017, 9, 659-671.
[23]
Saeedi, M.; Ansari, S.; Mahdavi, M.; Sabourian, R.; Akbarzadeh, T.; Foroumadi, A.; Shafiee, A. Synthesis of novel 1,2,3-triazole-dihydro [3,2-c]chromenones as acetylcholinesterase inhibitors. Synth. Commun., 2015, 45, 2311-2318.
[24]
Nikookar, H.; Mohammadi-Khanaposhtani, M.; Imanparast, S.; Faramarzi, M.A.; Ranjbar, P.R.; Mahdavi, M.; Larijani, B. Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano [3,2-c] quinoline derivatives as potential anti-diabetic agents. Bioorg. Chem., 2018, 77, 280-286.
[25]
Najafi, Z.; Saeedi, M.; Mahdavi, M.; Sabourian, R.; Khanavi, M.; Tehrani, M.B.; Moghadam, F.H.; Edraki, N.; Karimpor-Razkenari, E.; Sharifzadeh, M.; Foroumadi, A. Design and synthesis of novel anti-Alzheimer’s agents: Acridine-chromenone and quinoline-chromenone hybrids. Bioorg. Chem., 2016, 67, 84-94.
[26]
Najafi, Z.; Mahdavi, M.; Saeedi, M.; Karimpour-Razkenari, E.; Asatouri, R.; Vafadarnejad, F.; Moghadam, F.H.; Khanavi, M.; Sharifzadeh, M.; Akbarzadeh, T. Novel tacrine-1, 2, 3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors. Eur. J. Med. Chem., 2017, 125, 1200-1212.
[27]
Saeedi, M.; Golipoor, M.; Mahdavi, M.; Moradi, A.; Nadri, H.; Emami, S.; Foroumadi, A.; Shafiee, A. Phthalimidederived Nbenzylpyridinium halides targeting cholinesterases: Synthesis and bioactivity of new potential antiAlzheimer’s disease agents. Arch. Pharm., 2016, 349, 293-301.
[28]
Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods, 1983, 65, 55-63.

Rights & Permissions Print Cite
Article Metrics
33
2
1
1
© 2024 Bentham Science Publishers | Privacy Policy